Search company, investor...
Search

Predict your next investment

Bormioli Pharma company logo
Corporation
BUSINESS PRODUCTS & SERVICES | Packaging
bormiolipharma.com

See what CB Insights has to offer

Partners & Customers

2

About Bormioli Pharma

Bormioli Pharma specializes in healthcare packaging solutions and is based in Italy.

Bormioli Pharma Headquarters Location

Corso Magenta, 84

Milan, 20123,

Italy

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Bormioli Pharma Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Bormioli Pharma Rank

Bormioli Pharma Acquisitions

5 Acquisitions

Bormioli Pharma acquired 5 companies. Their latest acquisition was Cricef Contagocce on June 10, 2021.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

6/10/2021

$99M

Acquired

1

12/1/2020

Subscribe to see more

$99M

Subscribe to see more

10

4/16/2020

Subscribe to see more

$99M

Subscribe to see more

10

10/8/2019

Subscribe to see more

$99M

Subscribe to see more

10

9/23/2019

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/10/2021

12/1/2020

4/16/2020

10/8/2019

9/23/2019

Investment Stage

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

Note

Acquired

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

10

10

Bormioli Pharma Partners & Customers

2 Partners and customers

Bormioli Pharma has 2 strategic partners and customers. Bormioli Pharma recently partnered with Stevanato Group on February 2, 2020.

Date

Type

Business Partner

Country

News Snippet

Sources

2/4/2020

Partner

Italy

Stevanato Group and Bormioli Pharma sign a collaboration agreement for glass molded vials in EZ-fill® configuration - StevanatoGroup

Stevanato Group , through Ompi , its specialist in glass primary packaging for the pharmaceutical industry , and Bormioli Pharma announce today a collaboration agreement .

1

2/4/2020

Partner

Italy

Subscribe to see more

Subscribe to see more

10

Date

2/4/2020

2/4/2020

Type

Partner

Partner

Business Partner

Country

Italy

Italy

News Snippet

Stevanato Group and Bormioli Pharma sign a collaboration agreement for glass molded vials in EZ-fill® configuration - StevanatoGroup

Stevanato Group , through Ompi , its specialist in glass primary packaging for the pharmaceutical industry , and Bormioli Pharma announce today a collaboration agreement .

Subscribe to see more

Subscribe to see more

Sources

1

10

Bormioli Pharma Team

3 Team Members

Bormioli Pharma has 3 team members, including current Chief Executive Officer, Andrea Lodetti.

Name

Work History

Title

Status

Andrea Lodetti

Chief Executive Officer

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Andrea Lodetti

Subscribe to see more

Subscribe to see more

Work History

Title

Chief Executive Officer

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.